Dou­ble Bond Lo­ca­liza­ti­on in Li­pid Mass Spec­tro­me­try

In li­pid struc­tu­ral ana­ly­sis, the po­si­ti­on of a car­bon-car­bon dou­ble bond wi­thin a fat­ty acid chain is a de­fi­ning struc­tu­ral fea​ture—​not just its pre­sence. Li­pids with iden­ti­cal mole­cu­lar for­mu­las and the same num­ber of dou­ble bonds can dif­fer sub­stan­ti­al­ly in their bio­lo­gi­cal be­ha­vi­or de­pen­ding on exact­ly whe­re tho­se dou­ble bonds sit along the chain. This po­si­tio­nal in­for­ma­ti­on is cen­tral to un­der­stan­ding struc­tu­re-func­tion re­la­ti­onships in li­pi­do­mics, nut­ri­ti­on sci­ence, and cli­ni­cal li­pid re­se­arch.

Whe­re Con­ven­tio­nal Mass Spec­tro­me­try Falls Short

Stan­dard mass spec­tro­me­try work­flows are high­ly ef­fec­ti­ve at de­ter­mi­ning a li­pi­d’s mole­cu­lar for­mu­la, car­bon chain length, and over­all de­gree of sa­tu­ra­ti­on. What they ty­pi­cal­ly can­not re­sol­ve di­rect­ly is the exact po­si­ti­on of each dou­ble bond wi­thin the chain—​be​cau​se con­ven­tio­nal frag­men­ta­ti­on does not re­lia­bly break the mole­cu­le at that spe­ci­fic site.

To clo­se this gap, two es­tab­lished ap­proa­ches are wi­de­ly used:

  • Che­mi­cal de­ri­va­tiza­ti­on, such as Pa­ternò-Bü­chi re­ac­tions, which che­mi­cal­ly tag the dou­ble bond pri­or to ana­ly­sis
  • Ex­ter­nal ozono­ly­sis (OzID), which clea­ves dou­ble bonds using ozone ge­ne­ra­ted out­side the ion source

Both me­thods are ef­fec­ti­ve, but they share the same draw­back: they add a de­di­ca­ted re­agent, an ad­di­tio­nal re­ac­tion step, and in­creased me­thod com​ple​xi​ty​—a​long with the va­ria­bi­li­ty that ex­tra sam­ple hand­ling in­tro­du­ces.

The Me­cha­nism: In-Source Oxi­da­tive Cleava­ge via DBDI

Dielec­tric Bar­ri­er Di­schar­ge Io­niza­ti­on (DBDI), as im­ple­men­ted in SICRIT® tech­no­lo­gy, is a gas-pha­se, am­bi­ent io­niza­ti­on tech­ni­que, sit­ting along­side fa­mi­li­ar ap­proa­ches such as ESI, APCI, and APPI. What sets it apart is a me­cha­ni­stic side ef­fect: the ra­di­cal-dri­ven pro­ces­ses un­der­ly­ing DBD io­niza­ti­on also ge­ne­ra­te re­ac­ti­ve oxy­gen spe​ci​es—ef​fec​tively pro­du­cing ozone and per­oxi­de in­ter­me­dia­tes in situ.

This me­ans io­niza­ti­on and con­trol­led oxi­da­tive cleava­ge at the dou­ble bond can oc­cur wi­thin a se­ries of ra­di­cal re­ac­tions, di­rect­ly in the ion source, at the MS1 le​vel—​wi​th no ad­ded do­pants and no se­pa­ra­te de­ri­va­tiza­ti­on step.

The key con­trol­ling va­ria­ble is sol­vent com­po­si­ti­on. With an or­ga­nic, non­po­lar sol­vent gra­di­ent, li­pid spe­ci­es io­ni­ze nor­mal­ly and no cleava­ge is ob­ser­ved. Swit­ching to an aque­ous, po­lar sol­vent sys­tem ac­ti­va­tes the oxi­da­tive me­cha­nism, pro­du­cing con­trol­led, dou­ble-bond-spe­ci­fic cleava­ge for each un­sa­tu­ra­ti­on in the chain. This shifts dou­ble-bond lo­ca­liza­ti­on from a se­pa­ra­te ana­ly­ti­cal step to a pro­per­ty of the sol­vent sys­tem wi­thin an other­wi­se stan­dard LC-MS or di­rect-in­fu­si­on work­flow.

What the Me­thod De­li­vers

This aque­ous DBDI ap­proach has been shown to pro­du­ce con­sis­tent, dou­ble-bond-spe­ci­fic oxi­da­tive frag­ments across a ran­ge of li­pid clas­ses, in­clu­ding tria­cyl­gly­ce­rols (TAGs) of va­ry­ing sa­tu­ra­ti­on, as well as more po­lar li­pid clas­ses such as phos­pha­ti­dyl­etha­nol­ami­nes (PE), phos­pha­ti­dyl­cho­li­nes (PC), and cho­le­ste­ryl es­ters (Cho­lEs­ter). The re­sul­ting frag­ments are re­pro­du­ci­b­le and can be fur­ther con­firm­ed at the MS2 le­vel.

No­ta­b­ly, the me­thod also works wi­t­hout chro­ma­to­gra­phic se­pa­ra­ti­on: di­rect ana­ly­sis un­der hu­mi­di­fied con­di­ti­ons alo­ne is suf­fi­ci­ent to ge­ne­ra­te the cha­rac­te­ristic cleava­ge pat​tern—of​fe​ring a fas­ter al­ter­na­ti­ve for ap­pli­ca­ti­ons whe­re full LC se­pa­ra­ti­on is­n’t re­qui­red.

Out­look

Com­pared to do­pant-as­sis­ted ozono­ly­sis or de­ri­va­tiza­ti­on-ba­sed me­thods, this DBDI-ba­sed ap­proach re­mo­ves the need for ex­ter­nal do­pants and ad­di­tio­nal me­thod steps, while working wi­thin the io­niza­ti­on step re­se­ar­chers al­re­a­dy rely on. On­go­ing work fo­cu­ses on fur­ther op­ti­mi­zing sol­vent and gas con­di­ti­ons to in­crease the yield of in-source oxi­da­tive ra­di­cal spe­ci­es, with the goal of im­pro­ving sen­si­ti­vi­ty and broa­de­ning ap­pli­ca­bi­li­ty across li­pid clas­ses.

This me­cha­nism builds on the broa­der ca­pa­bi­li­ties of SICRIT® io­niza­ti­on tech­no­lo­gy, which sup­ports a wide po­la­ri­ty ran­ge of ana­lytes bey­ond li­pid struc­tu­ral ana­ly­sis.

This post was crea­ted with the as­sis­tance of AI and edi­to­ri­al­ly re­view­ed.